Biopharma CEO Investor Forum

Biopharma companies are actively working to enhance their sustainability efforts to increase the emphasis on long-term value creation, stakeholder engagement, and forward-looking disclosures. To support these efforts, the Biopharma Sustainability Roundtable (BSRT) partnered with CECP’s CEO Investor Forum, to co-host the first sector-specific CEO-Investor Forum that took place on June 7-8, 2021.

Event Highlights

Opening Remarks

Closing Remarks

Alex Gorsky, Johnson & Johnson

Christophe Weber, Takeda

Paul Hudson, Sanofi

Kenneth Frazier, Merck

Jean-Christophe Tellier, UCB

Albert Bourla, Pfizer

Hervé Hoppenot, Incyte

Stéphane Bancel, Moderna

Emma Walmsley, GlaxoSmithKline

John Chiminski, Catalent

Trend Talk

Panel Discussion

CEOs leveraged CECP’s Long-Term Plan Framework and the Biopharma Investor ESG Communications Guidance to tailor the content of their presentations for this investor-focused event.

"We are delighted to collaborate with the CEO Investor Forum to create tools for biopharma companies to effectively incorporate ESG strategies into their long-term plans, and to create this unique opportunity for sector CEOs to share their long-term vision."

Sandor Schoichet

Co-Founder of the Biopharma Sustainability Roundtable

“In order to serve this sector, we will cross-reference the BSRT’s recently published Biopharma Investor ESG Communications Guidance to apply a biopharma lens to the CEO Investor Forum’s Long-Term Plan framework to identify critical business factors and their associated metrics that are decision-relevant to the biopharma industry, this partnership will support leading biotech and pharma companies as they develop and share forward-looking metrics, including financially material ESG metrics, with their key stakeholders.”

Brian Tomlinson

Director of Research at the CEO Investor Forum

Leading up to the event, BSRT and the CEO Investor Forum released an executive report, “Integrating Sustainability and Long-term Planning for the Biopharma Sector,” and a companion practitioner’s guide to support biopharma CEOs and their teams as they prepared their sustainable long-term plans for investors.

Learn More

Biopharma CEO Investor Forum

June 7th-8th, 2021

The Biopharma Sustainability Roundtable (BSRT) and CECP’s CEO Investor Forum invite you to join nine leading leading biopharma CEOs for the first-ever sector-specific Biopharma CEO Investor Forum, June 7-8, 2021. CEOs from Catalent, GlaxoSmithKline, Incyte, Merck & Co., Moderna, Pfizer, Sanofi, Takeda, and UCB will share their Long-Term Plans for sustainable value creation with leading institutional investors and the wider stakeholder community.

Integrating Sustainability Into Biopharma Strategy

May 13, 2021

Sandor Schoichet and Thomas Scheiwiller discuss the drive toward integrating environmental, social, and governance (ESG) topics into biopharma business planning, and communicating effectively about ESG performance with capital markets.

Listen on Soundcloud or Apple Podcasts